SERENE ER Analysis Part 2 SERENE-UC: Exposure-response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Ulcerative Colitis
PMID: 38953600
Source: Clin Pharmacol Drug Dev
Publication date:
2025-07-24
Year:
2024
Abstract
NULL